JCR Pharmaceuticals Co., Ltd.(JP:4552)
¥480.00-14.00 (-2.83%)
JP:4552
JCR Pharmaceuticals Co., Ltd. earnings date
¥480.00
At close:-14.00 (-2.83%)
Want to see JP:4552 full AI Analyst Report?
JCR Pharmaceuticals Co., Ltd. (4552) Q4 2024 Earnings Report
1 Followers
JP:4552 Q4 2024 EPS Results
- Actual EPS
- -JPY 33.80
- Consensus EPS
- -JPY 53.70
- Beat/Miss
- Beat by +JPY 19.90
- One Year Ago EPS
- JPY 2.78
JP:4552 Q4 2024 Revenue Results
- Actual Revenue
- JPY 7.19B
- Expected Revenue
- JPY 7.15B
- Beat/Miss
- Beat by +JPY 45.09M
- YoY Revenue Growth
- -21.42%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 05/13/2025
- Time
- TBA
- Conference Call
- Tuesday, May 13, 2025
JP:4552 Upcoming Earnings
JCR Pharmaceuticals Co., Ltd.'s next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4552 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | -13.83- | 0.27 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | ―-16.03 | 18.51 | -186.60% (-34.54) | |
| Jul 30, 2026 | 2026 (Q1) | -11.27-15.64 | -4.48 | -249.11% (-11.16) | |
| May 13, 2026 | 2025 (Q4) | -6.633.57 | -33.8 | 110.56% (+37.37) | |
| Jan 28, 2026 | 2025 (Q3) | -1.070.27 | 0.9 | -70.00% (-0.63) | |
| Oct 30, 2025 | 2025 (Q2) | 20.3918.51 | -7.14 | 359.24% (+25.65) | |
| Jul 30, 2025 | 2025 (Q1) | 4.36-4.48 | 1.61 | -378.26% (-6.09) | |
| May 13, 2025 | 2024 (Q4) | -53.70-33.80 | 2.78 | -1315.83% (-36.58) | |
| Jan 31, 2025 | 2024 (Q3) | 11.180.90 | -0.75 | 220.00% (+1.65) | |
| Oct 30, 2024 | 2024 (Q2) | 13.72-7.14 | 29.19 | -124.46% (-36.33) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

